For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of SMS PHARMA. For more details, see the SMS PHARMA quarterly results and SMS PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.8 |
No. of shares | m | 84.65 |
1 Week | % | -0.9 |
1 Month | % | -3.8 |
1 Year | % | 138.7 |
52 week H/L | Rs | 219.3/75.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SMS PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 91 | 68 | 140 | 199 | 110 | |
Low | Rs | 55 | 24 | 27 | 85 | 55 | |
Sales per share (Unadj.) | Rs | 50.5 | 44.1 | 61.3 | 57.4 | 58.1 | |
Earnings per share (Unadj.) | Rs | 4.9 | 3.9 | 7.2 | 8.0 | 0.5 | |
Diluted earnings per share | Rs | 4.9 | 3.9 | 7.2 | 8.0 | 0.5 | |
Cash flow per share (Unadj.) | Rs | 7.2 | 6.5 | 9.8 | 11.8 | 4.3 | |
Dividends per share (Unadj.) | Rs | 0.25 | 0.25 | 0.30 | 0.30 | 0.30 | |
Adj. dividends per share | Rs | 0.25 | 0.25 | 0.30 | 0.30 | 0.30 | |
Avg Dividend yield | % | 0.3 | 0.5 | 0.4 | 0.2 | 0.4 | |
Book value per share (Unadj.) | Rs | 38.0 | 41.1 | 48.5 | 55.6 | 54.4 | |
Adj. book value per share | Rs | 38.0 | 41.1 | 48.5 | 55.6 | 54.4 | |
Shares outstanding (eoy) | m | 84.65 | 84.65 | 84.65 | 84.65 | 84.65 | |
Price / Sales ratio | x | 1.4 | 1.0 | 1.4 | 2.5 | 1.4 | |
Avg P/E ratio | x | 14.9 | 11.8 | 11.6 | 17.7 | 179.4 | |
P/CF ratio (eoy) | x | 10.2 | 7.0 | 8.5 | 12.0 | 19.3 | |
Price / Book Value ratio | x | 1.9 | 1.1 | 1.7 | 2.6 | 1.5 | |
Dividend payout | % | 5.1 | 6.5 | 4.2 | 3.7 | 65.4 | |
Avg Mkt Cap | Rs m | 6,169 | 3,854 | 7,068 | 12,027 | 6,967 | |
Total wages/salary | Rs m | 356 | 394 | 412 | 510 | 550 |
SMS PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,275 | 3,730 | 5,189 | 4,858 | 4,914 | |
Other income | Rs m | 34 | 51 | 35 | 52 | 49 | |
Total revenues | Rs m | 4,309 | 3,781 | 5,224 | 4,910 | 4,963 | |
Gross profit | Rs m | 901 | 800 | 1,211 | 1,146 | 546 | |
Depreciation | Rs m | 193 | 221 | 223 | 322 | 321 | |
Interest | Rs m | 119 | 123 | 112 | 192 | 220 | |
Profit before tax | Rs m | 624 | 508 | 911 | 685 | 53 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 209 | 181 | 302 | 6 | 15 | |
Profit after tax | Rs m | 415 | 327 | 610 | 679 | 39 | |
Gross profit margin | % | 21.1 | 21.5 | 23.3 | 23.6 | 11.1 | |
Effective tax rate | % | 33.5 | 35.6 | 33.1 | 0.9 | 27.4 | |
Net profit margin | % | 9.7 | 8.8 | 11.7 | 14.0 | 0.8 |
SMS PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,211 | 2,278 | 3,253 | 3,921 | 4,107 | |
Current liabilities | Rs m | 1,561 | 1,542 | 2,114 | 2,115 | 2,550 | |
Net working cap to sales | % | 15.2 | 19.7 | 21.9 | 37.2 | 31.7 | |
Current ratio | x | 1.4 | 1.5 | 1.5 | 1.9 | 1.6 | |
Inventory Days | Days | 44 | 65 | 27 | 25 | 18 | |
Debtors Days | Days | 222 | 477 | 743 | 365 | 1,102 | |
Net fixed assets | Rs m | 3,512 | 3,891 | 5,029 | 4,825 | 4,690 | |
Share capital | Rs m | 85 | 85 | 85 | 85 | 85 | |
"Free" reserves | Rs m | 3,135 | 3,398 | 4,021 | 4,618 | 4,521 | |
Net worth | Rs m | 3,219 | 3,482 | 4,105 | 4,703 | 4,605 | |
Long term debt | Rs m | 622 | 682 | 1,474 | 1,495 | 1,211 | |
Total assets | Rs m | 5,723 | 6,169 | 8,282 | 8,745 | 8,797 | |
Interest coverage | x | 6.2 | 5.1 | 9.1 | 4.6 | 1.2 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.4 | 0.3 | 0.3 | |
Sales to assets ratio | x | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | |
Return on assets | % | 9.3 | 7.3 | 8.7 | 10.0 | 2.9 | |
Return on equity | % | 12.9 | 9.4 | 14.9 | 14.4 | 0.8 | |
Return on capital | % | 19.3 | 15.1 | 18.3 | 14.1 | 4.7 | |
Exports to sales | % | 14.1 | 26.3 | 26.2 | 26.1 | 64.4 | |
Imports to sales | % | 1.5 | 3.7 | 9.8 | 21.3 | 25.7 | |
Exports (fob) | Rs m | 603 | 981 | 1,359 | 1,267 | 3,165 | |
Imports (cif) | Rs m | 65 | 139 | 509 | 1,035 | 1,261 | |
Fx inflow | Rs m | 603 | 981 | 1,359 | 1,267 | 3,165 | |
Fx outflow | Rs m | 138 | 181 | 757 | 1,042 | 1,270 | |
Net fx | Rs m | 465 | 800 | 603 | 225 | 1,895 |
SMS PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 498 | 397 | 905 | 451 | 225 | |
From Investments | Rs m | -347 | -426 | -1,516 | -272 | -297 | |
From Financial Activity | Rs m | -129 | -24 | 920 | -117 | -320 | |
Net Cashflow | Rs m | 22 | -53 | 309 | 62 | -392 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ramesh Babu | COMP SEC: Thirumalesh Tumma | YEAR OF INC: 1987 | BSE CODE: 532815 | FV (Rs): 1 | DIV YIELD (%): 0.1 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SMS PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.